BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 20368972)

  • 1. Cryptococcus neoformans overcomes stress of azole drugs by formation of disomy in specific multiple chromosomes.
    Sionov E; Lee H; Chang YC; Kwon-Chung KJ
    PLoS Pathog; 2010 Apr; 6(4):e1000848. PubMed ID: 20368972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heteroresistance to fluconazole in Cryptococcus neoformans is intrinsic and associated with virulence.
    Sionov E; Chang YC; Garraffo HM; Kwon-Chung KJ
    Antimicrob Agents Chemother; 2009 Jul; 53(7):2804-15. PubMed ID: 19414582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the chromosome 4 genes that affect fluconazole-induced disomy formation in Cryptococcus neoformans.
    Ngamskulrungroj P; Chang Y; Hansen B; Bugge C; Fischer E; Kwon-Chung KJ
    PLoS One; 2012; 7(3):e33022. PubMed ID: 22412978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cryptococcus neoformans, Unlike Candida albicans, Forms Aneuploid Clones Directly from Uninucleated Cells under Fluconazole Stress.
    Chang YC; Khanal Lamichhane A; Kwon-Chung KJ
    mBio; 2018 Dec; 9(6):. PubMed ID: 30514783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cryptococcus neoformans Yop1 , an endoplasmic reticulum curvature-stabilizing protein, participates with Sey1 in influencing fluconazole-induced disomy formation.
    Ngamskulrungroj P; Chang Y; Hansen B; Bugge C; Fischer E; Kwon-Chung KJ
    FEMS Yeast Res; 2012 Nov; 12(7):748-54. PubMed ID: 22731401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide expression profiling of the response to short-term exposure to fluconazole in Cryptococcus neoformans serotype A.
    Florio AR; Ferrari S; De Carolis E; Torelli R; Fadda G; Sanguinetti M; Sanglard D; Posteraro B
    BMC Microbiol; 2011 May; 11():97. PubMed ID: 21569340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Azole heteroresistance in Cryptococcus neoformans: emergence of resistant clones with chromosomal disomy in the mouse brain during fluconazole treatment.
    Sionov E; Chang YC; Kwon-Chung KJ
    Antimicrob Agents Chemother; 2013 Oct; 57(10):5127-30. PubMed ID: 23836187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a Cryptococcus neoformans cytochrome P450 lanosterol 14α-demethylase (Erg11) residue critical for differential susceptibility between fluconazole/voriconazole and itraconazole/posaconazole.
    Sionov E; Chang YC; Garraffo HM; Dolan MA; Ghannoum MA; Kwon-Chung KJ
    Antimicrob Agents Chemother; 2012 Mar; 56(3):1162-9. PubMed ID: 22155829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coregulation of extracellular vesicle production and fluconazole susceptibility in
    Rizzo J; Trottier A; Moyrand F; Coppée JY; Maufrais C; Zimbres ACG; Dang TTV; Alanio A; Desnos-Ollivier M; Mouyna I; Péhau-Arnaude G; Commere PH; Novault S; Ene IV; Nimrichter L; Rodrigues ML; Janbon G
    mBio; 2023 Aug; 14(4):e0087023. PubMed ID: 37310732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deletion of Cryptococcus neoformans AIF ortholog promotes chromosome aneuploidy and fluconazole-resistance in a metacaspase-independent manner.
    Semighini CP; Averette AF; Perfect JR; Heitman J
    PLoS Pathog; 2011 Nov; 7(11):e1002364. PubMed ID: 22114551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multi-azole-resistant strains of Cryptococcus neoformans var. grubii isolated from a FLZ-resistant strain by culturing in medium containing voriconazole.
    Kano R; Okubo M; Hasegawa A; Kamata H
    Med Mycol; 2017 Nov; 55(8):877-882. PubMed ID: 28927230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colony and Single Cell Level Analysis of the Heterogeneous Response of
    Altamirano S; Simmons C; Kozubowski L
    Front Cell Infect Microbiol; 2018; 8():203. PubMed ID: 29971221
    [No Abstract]   [Full Text] [Related]  

  • 13. Azole drugs are imported by facilitated diffusion in Candida albicans and other pathogenic fungi.
    Mansfield BE; Oltean HN; Oliver BG; Hoot SJ; Leyde SE; Hedstrom L; White TC
    PLoS Pathog; 2010 Sep; 6(9):e1001126. PubMed ID: 20941354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of fluconazole heteroresistance in clinical and environmental isolates of Cryptococcus neoformans complex and Cryptococcus gattii complex in the state of Amazonas, Brazil.
    Moreira IMB; Cortez ACA; de Souza ÉS; Pinheiro SB; de Souza Oliveira JG; Sadahiro A; Cruz KS; Matsuura ABJ; Melhem MSC; Frickmann H; de Souza JVB
    Med Mycol; 2022 Mar; 60(3):. PubMed ID: 35084497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amino acid substitution in Cryptococcus neoformans lanosterol 14-α-demethylase involved in fluconazole resistance in clinical isolates.
    Bosco-Borgeat ME; Mazza M; Taverna CG; Córdoba S; Murisengo OA; Vivot W; Davel G
    Rev Argent Microbiol; 2016; 48(2):137-42. PubMed ID: 27311753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First Isolation of Azole-Resistant Cryptococcus neoformans from Feline Cryptococcosis.
    Kano R; Okubo M; Yanai T; Hasegawa A; Kamata H
    Mycopathologia; 2015 Dec; 180(5-6):427-33. PubMed ID: 26162642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and properties of plasma membrane azole efflux pumps from the pathogenic fungi Cryptococcus gattii and Cryptococcus neoformans.
    Basso LR; Gast CE; Bruzual I; Wong B
    J Antimicrob Chemother; 2015 May; 70(5):1396-407. PubMed ID: 25630649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic ploidy changes drive fluconazole resistance in human cryptococcal meningitis.
    Stone NR; Rhodes J; Fisher MC; Mfinanga S; Kivuyo S; Rugemalila J; Segal ES; Needleman L; Molloy SF; Kwon-Chung J; Harrison TS; Hope W; Berman J; Bicanic T
    J Clin Invest; 2019 Mar; 129(3):999-1014. PubMed ID: 30688656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Azole resistance in Cryptococcus gattii from the Pacific Northwest: Investigation of the role of ERG11.
    Gast CE; Basso LR; Bruzual I; Wong B
    Antimicrob Agents Chemother; 2013 Nov; 57(11):5478-85. PubMed ID: 23979758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions between triazoles and amphotericin B against Cryptococcus neoformans.
    Barchiesi F; Schimizzi AM; Caselli F; Novelli A; Fallani S; Giannini D; Arzeni D; Di Cesare S; Di Francesco LF; Fortuna M; Giacometti A; Carle F; Mazzei T; Scalise G
    Antimicrob Agents Chemother; 2000 Sep; 44(9):2435-41. PubMed ID: 10952592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.